|Application:||Gene expression microarray analysis|
|Number of samples:||61|
|Release date:||Feb 19 2014|
|Last update date:||Aug 13 2018|
|Diseases:||Melanoma, Neoplasms, Tumor Lysis Syndrome|
|Dataset link||Spectrum, clinical correlates and clinical implications of BRAF-inhibitor resistance mechanisms in melanoma|
Total RNA was obtained from fresh-frozen melanoma tumour samples from patients before commencing treatment with dabrafenib or vemurafenib and at time of tumour progression.